KORU Medical Systems Inc. Common Stock (DE)
KORU Medical Systems Inc. Common Stock (DE) (KRMD): 8 pipeline candidates · 1 upcoming catalyst · ~5 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
4.6 months
D/E 0.69 · 1% dilution
Lead: Approved
8 candidates
1 upcoming, next in ~4562d
5 buys · 0 sells (180d)
A transparent, data-derived signal for KORU Medical Systems Inc. Common Stock (DE)across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$178.7M
Cash
$8.8M
Quarterly Burn
$8.1M
Runway
4.6 mo
Revenue
$11.8M
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (8 candidates)
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
86
Total value held
$56.3M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 3,372,448 | $14.6M |
| blackrock, inc. | 2,371,826 | $10.2M |
| geode capital management, llc | 1,051,208 | $4.5M |
| meros investment management, lp | 760,451 | $3.3M |
| state street corp | 649,229 | $2.8M |
| russell investments group, ltd. | 423,419 | $1.8M |
| morgan stanley | 369,026 | $1.6M |
| northern trust corp | 322,252 | $1.4M |
| vanguard fiduciary trust co | 306,453 | $1.3M |
| vanguard portfolio management llc | 255,455 | $1.1M |
Showing top 10 of 86 institutional holders of KORU Medical Systems Inc. Common Stock (DE). Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in KORU Medical Systems Inc. Common Stock (DE)'s pipeline?
KORU Medical Systems Inc. Common Stock (DE) (KRMD) has 8 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is KORU Medical Systems Inc. Common Stock (DE)'s lead drug candidate?
KORU Medical Systems Inc. Common Stock (DE)'s most advanced tracked candidate is cutaquig (Approved) for Primary Immunodeficiency Diseases (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
What is KORU Medical Systems Inc. Common Stock (DE)'s next catalyst?
KORU Medical Systems Inc. Common Stock (DE)'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: EMPAVELI" — expected December 14, 2038.
What is KORU Medical Systems Inc. Common Stock (DE)'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, KORU Medical Systems Inc. Common Stock (DE) has approximately 4.6 months of cash runway.
What is KORU Medical Systems Inc. Common Stock (DE)'s market capitalization?
KORU Medical Systems Inc. Common Stock (DE)'s market capitalization is approximately $178.7M.
Get the full picture on KORU Medical Systems Inc. Common Stock (DE)
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.